Shanghai Fosun Pharmaceutical | Mutual Funds
Mutual Funds that own Shanghai Fosun Pharmaceutical
Vanguard International Value Fund
14,844,000
2.69%
0
0.6%
06/30/2018
American Funds Developing World Growth & Income Fund
11,812,000
2.14%
-693,500
1.75%
06/30/2018
Vanguard Health Care Fund
10,387,500
1.88%
-1,502,000
0.08%
06/30/2018
Government Pension Fund - Global (The)
9,129,255
1.65%
-11,834,250
0%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
8,354,810
1.51%
945,911
0.04%
07/31/2018
7,899,500
1.43%
7,899,500
2.41%
06/30/2017
Vanguard Total International Stock Index Fund
7,730,187
1.4%
1,112,058
0.01%
07/31/2018
6,886,500
1.25%
800,500
0.4%
03/31/2018
American Funds Emerging Markets Growth Fund
6,286,094
1.13%
-345,500
1.07%
03/31/2018
CIP - Group Emerging Markets Total Opportunities (LUX)
5,058,000
0.92%
-953,000
0.77%
03/31/2018
| Address |
Building A
Shanghai Shanghai 200233
China
|
|
Employees
|
- |
| Website |
http://www.fosunpharma.com |
| Updated |
07/08/2019 |
| Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. |
